Want to join the conversation?
$MCHP FY15 10-K: 2015 total OpEx increased 20% to $803.94MM vs. $669.88MM in 2014. Total OpEx in 2013 was $659.91MM. R&D expenses increased 14.6% to $349.54MM vs. $305.04MM in 2014. 2013 R&D expenses were $254.72MM vs. $182.65MM in 2012. SG&A expenses increased approx. 3% to $274.82MM vs. $267.28MM in 2014.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.